A case of primary sclerosing cholangitis with no recurrence and a good outcome for more than 20 years after living donor liver transplantation
Author:
Affiliation:
1. Department of Postgraduate Training Center, Kawasaki Medical Center, Kawasaki Medical School
2. Department of General Internal Medicine2, Kawasaki Medical School
3. Department of Surgery, Graduate School of Medicine, Kyoto University
Publisher
Japan Society of Hepatology
Link
https://www.jstage.jst.go.jp/article/kanzo/65/2/65_66/_pdf
Reference18 articles.
1. 1) 厚生労働省難知性疾患研究事業 難知性の肝・胆道疾患に関する研究調査原発性硬化性胆管炎. http://www.hepatobiliary.jp/modules/disease/index.php?content_id=3
2. 2) Takikawa H. [National Survey of PSC]. In: Health and Labour Sciences Research Grant Research on Measures for Intractable Diseases, 2008
3. 3) Isayama H, Tazuma S, Kokudo N, et al. Clinical guidelines for primary sclerosing cholangitis. 2017 J Gastroenterol 2018; 53: 1006-1034
4. 4) Ueda Y, Kaido T, Okajima H, et al. Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience. Transplant Direct 2017; 3: e334
5. 5) Sabino J, Vieira-Silva S, Machiels K, et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 2016; 65: 1681-1689
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3